Highland Private Wealth Management’s Perspective Therapeutics CATX Stock Holding History

Highland Private Wealth Management’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-97,204	Closed	-$377K	–	190
2021 Q4	$377K	Buy	97,204 +12,500	+15%	+$66.7K	0.05%	118
2021 Q3	$534K	Hold	84,704	–	–	0.08%	89
2021 Q2	$676K	Hold	84,704	–	–	0.1%	73
2021 Q1	$923K	Buy	84,704 +23,654	+39%	+$357K	0.15%	55
2020 Q4	$275K	Buy	61,050 +6,800	+13%	+$30K	0.05%	117
2020 Q3	$316K	Hold	54,250	–	–	0.06%	97
2020 Q2	$301K	Hold	54,250	–	–	0.06%	92
2020 Q1	$288K	Buy	54,250 +26,250	+94%	+$198K	0.08%	87
2019 Q4	$175K	Buy	28,000 +15,000	+115%	+$65.8K	0.04%	129
2019 Q3	$42K	Hold	13,000	–	–	0.01%	121
2019 Q2	$53K	Hold	13,000	–	–	0.02%	124
2019 Q1	$47K	Hold	13,000	–	–	0.01%	118
2018 Q4	$39K	Buy	+13,000	New	+$55.7K	0.01%	98

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TMWM

Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Highland Private Wealth Management's CATX Position: Q1 2022 in Review

Highland Private Wealth Management sold out of Perspective Therapeutics (CATX) in Q1 2022, closing a stake of 97,204 shares — an estimated $377K sold.

Highland Private Wealth Management first reported a position in CATX in Q4 2018 and held it in 13 quarters. The position peaked at $923K in Q1 2021. 39 funds tracked by Wall St. Rank hold CATX as of Q1 2022.

Highland Private Wealth Management reported no remaining Perspective Therapeutics position as of Q1 2022 after selling out during the quarter.
Highland Private Wealth Management sold 97,204 Perspective Therapeutics shares in Q1 2022, an estimated $377K.
Highland Private Wealth Management first reported a position in Perspective Therapeutics in Q4 2018 and held it in 13 quarters.
Highland Private Wealth Management's Perspective Therapeutics position peaked at $923K in Q1 2021.
39 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2022.

Based on Highland Private Wealth Management's 13F filing for Q1 2022, filed 28 Apr 2022.